Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Medtronic
Express Scripts
AstraZeneca
Mallinckrodt

Last Updated: August 15, 2022

Investigational Drug Information for Tideglusib


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Tideglusib?

Tideglusib is an investigational drug.

There have been 8 clinical trials for Tideglusib. The most recent clinical trial was a Phase 2 trial, which was initiated on March 3rd 2021.

The most common disease conditions in clinical trials are Myotonic Dystrophy, Alzheimer Disease, and Supranuclear Palsy, Progressive. The leading clinical trial sponsors are AMO Pharma Limited, Noscira SA, and University of Toronto.

There are thirty-seven US patents protecting this investigational drug and two hundred and eight international patents.

Recent Clinical Trials for Tideglusib
TitleSponsorPhase
Tideglusib for the Treatment of Amyotrophic Lateral SclerosisCantonal Hospital of St. GallenPhase 2
Tideglusib for the Treatment of Amyotrophic Lateral SclerosisUniversity of BernPhase 2
Tideglusib for the Treatment of Amyotrophic Lateral SclerosisUniversity of Lausanne HospitalsPhase 2

See all Tideglusib clinical trials

Clinical Trial Summary for Tideglusib

Top disease conditions for Tideglusib
Top clinical trial sponsors for Tideglusib

See all Tideglusib clinical trials

US Patents for Tideglusib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tideglusib See Plans and Pricing Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: III Frequency Therapeutics, Inc. (Woburn, MA) See Plans and Pricing
Tideglusib See Plans and Pricing .beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof Quadriga Biosciences, Inc. (Los Altos, CA) See Plans and Pricing
Tideglusib See Plans and Pricing Compositions and methods for treating cancers CEDARS-SINAI MEDICAL CENTER (Los Angeles, CA) See Plans and Pricing
Tideglusib See Plans and Pricing Reprogramming fibroblasts into cardiomyocytes THE J. DAVID GLADSTONE INSTITUTES, A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID GLADSTONE (San Francisco, CA) See Plans and Pricing
Tideglusib See Plans and Pricing Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I Frequency Therapeutics, Inc. (Woburn, MA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tideglusib

Drugname Country Document Number Estimated Expiration Related US Patent
Tideglusib Argentina AR105592 2035-08-03 See Plans and Pricing
Tideglusib Australia AU2016302243 2035-08-03 See Plans and Pricing
Tideglusib Canada CA2994404 2035-08-03 See Plans and Pricing
Tideglusib China CN108026026 2035-08-03 See Plans and Pricing
Tideglusib European Patent Office EP3331851 2035-08-03 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Medtronic
Express Scripts
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.